Regenesis Biomedical, Inc

11 articles about Regenesis Biomedical, Inc

• Regenesis Achieves FDA Clearance for the New Reprieve by Regenesis™ Device

  8/22/2023

  Regenesis Biomedical, Inc., a medical devic­­e company focused on safe, non-drug, pain management, announced today commercialization of the new Reprieve by Regenesis™ device (Reprieve).

• Regenesis Biomedical Names Tom Eisiminger, Jr., Chief Executive Officer

  1/11/2021

  Regenesis Biomedical, Inc., a medical device company focused on safe, non-drug, pain management, announced today that the Board of Directors has unanimously elected Mr. Tom Eisiminger, Jr. , as the next President and Chief Executive Officer

• Regenesis Biomedical, Inc. Named Arizona Bioscience Company of the Year

  9/16/2019

  The Arizona Bioindustry Association (AZBio) today announced that Regenesis Biomedical, Inc. has been named the Arizona Bioscience Company of the Year and will be honored on October 2, 2019, at the AZBio Awards.

• FDA Clears Regenesis Biomedical'S Provant Therapy System For Use By Patients With Metallic Implants

  12/19/2013

• Regenesis Biomedical Taps New CEO After Death of Virginia Rybski

  5/15/2013

• Regenesis Biomedical to Expand Payor Sources to Increase Patient Access

  1/9/2012

• Regenesis Biomedical Announces $5.3 Million in Series C Funding

  6/6/2011

• Regenesis Biomedical Announces Additions to Board of Directors

  8/25/2008

• Regenesis Biomedical Appoints Scientific Advisory Board

  5/21/2008

• Regenesis Biomedical Appoints Vice President of Marketing

  5/1/2008

• Wound Care Company Regenesis Biomedical Raises $527K In Series B

  9/5/2006